ClinicalTrials.govpublic full text
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
pancreatic cancer, breast cancer, gastric cancer, non-small cell lung cancer, cervical cancer, endocervical cancer, squamous cell carcinoma of head and neck, bladder urothelial cancer, colorectal carcinoma, esophageal cancer, ovarian cancer, renal cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 824951
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.